18F-FDG PET/CT in the follow-up of large-vessel vasculitis: A study of 37 consecutive patients
Ver/ Abrir
Registro completo
Mostrar el registro completo DCAutoría
Martínez Rodríguez, Mª Isabel; Jiménez Alonso, Mikel; Quirce Pisano, María Remedios



Fecha
2018-02Derechos
© <2018> Elsevier. This manuscript version is made available under the CC-BY-NC-ND 4.0 license
Publicado en
Seminars in Arthritis and Rheumatism
Volume 47, Issue 4, February 2018, Pages 530-537
Editorial
Elsevier
Enlace a la publicación
Palabras clave
Large vessel vasculitis
Aortitis, giant cell arteritis
18F-FDG PET/CT
Positrón emission tomography
Resumen/Abstract
Objective
18F-FDG PET/CT has proved to be of potential value for early diagnosis of large-vessel vasculitis (LVV), which frequently involves the aorta. However, its role in the follow-up of these patients has not been well established. Our aim was to evaluate the contribution of 18F-FDG PET/CT in this clinical situation.
Methods
This study included 37 consecutive patients (28 women, 66.5 ± 9.9 years) with an initial 18F-FDG PET/CT positive for LVV and a mean ± standard deviation follow-up PET/CT of 7.5 ± 2.9 months after the initial scan. A semiquantitative analysis of aortic wall uptake was performed calculating the target-to-background ratio (TBR: aortic wall uptake divided by blood pool uptake). The initial and follow-up TBR as well as the clinical and laboratory outcome were compared.
Results
Overall, the mean TBR decreased from 1.7 ± 0.5 at the initial scan to 1.5 ± 0.3 at the time of follow-up (p = 0.0001). In the 21 patients who experienced clinical improvement following therapy the TBR also decreased from 1.8 ± 0.6 to 1.5 ± 0.3 (p = 0.0002). However, in the other 16 patients, in whom the treating physician considered that there was no clinical improvement following therapy, no statistically significant differences in TBR were found when data from the first and the follow-up PET/CT scans were compared (1.6 ± 0.3 versus 1.5 ± 0.3, p = 0.1416). Patients who experienced clinical improvement following therapy showed a nonstatistically significant higher TBR at the time of disease diagnosis (1.8 ± 0.6 versus 1.6 ± 0.3; p = 0.12).
Conclusions
The results obtained in the present study highlight the impact of 18F-FDG PET/CT on the management of patients with LVV.
Colecciones a las que pertenece
- D06 Artículos [576]